Auxílio à pesquisa 09/52825-8 - Neurobiologia, Doença de Alzheimer - BV FAPESP
Busca avançada
Ano de início
Entree

Neurobiologia da doença de Alzheimer: marcadores de risco, prognóstico e resposta terapêutica

Resumo

Por meio de dois projetos temáticos apoiados pela FAPESP desde 1997, nosso laboratório desenvolve pesquisa translacional aplicada à análise de anormalidades do metabolismo de fosfolípides de membrana, sua influência na homeostase cerebral e suas implicações em doenças neuropsiquiátricas. No presente projeto, avaliaremos múltiplos mecanismos biológicos relacionados à fisiopatologia da Doença de Alzheimer (DA), buscando os correlatos clínicos que determinam um maior risco de demência em pacientes idosos com transtornos cognitivos e do humor. Este projeto Temático é dividido em dois módulos. No módulo 1 (Estudos Clínicos, Laboratoriais e de Neuroimagem), determinaremos de forma integrada os marcadores biológicos que influenciam o risco, o curso clínico e a resposta terapêutica; avaliaremos polimorfismos genéticos, biomarcadores em líquor e sangue periférico, e parâmetros de imagem cerebral estrutural e funcional (MRS e PET). Nosso maior interesse é estabelecer o diagnóstico precoce da DA e avaliar a eficácia de intervenções farmacológicas e não farmacológicas sobre a atenuação das perdas cognitivas, almejando a prevenção da demência. No módulo 2 (Neuroquímica e Biologia Molecular), utilizaremos modelos experimentais in vitro (culturas primárias de neurônios) e in vivo (camundongos transgênicos que acumulam peptídeo beta-amilóide, Aβ) para estudar os mecanismos moleculares que inter-relacionam diferentes processos patogênicos. Avaliaremos a toxicidade do Aβ e seu impacto sobre a neurogênese, a atividade enzimática e a expressão gênica. Em modelos pré-clínicos, investigaremos a possibilidade de modificar estes processos pelo tratamento com lítio, dadas suas propriedades neurotróficas e neuroprotetoras, integrando assim as vertentes experimentais e clínicas deste projeto. (AU)

Matéria(s) publicada(s) na Agência FAPESP sobre o auxílio:
Mais itensMenos itens
Matéria(s) publicada(s) em Outras Mídias ( ):
Mais itensMenos itens
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Publicações científicas (55)
(Referências obtidas automaticamente do Web of Science e do SciELO, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores)
DE OLIVEIRA, ALEXANDRA MARTINI; RADANOVIC, MARCIA; HOMEM DE MELLO, PATRICIA COTTING; BUCHAIN, PATRICIA CARDOSO; BARBOSA VIZZOTTO, ADRIANA DIAS; CELESTINO, DIEGO L.; STELLA, FLORINDO; PIERSOL, CATHERINE V.; FORLENZA, ORESTES V.. Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review. BIOMED RESEARCH INTERNATIONAL, . (09/52825-8)
DE OLIVEIRA, ALEXANDRA MARTINI; RADANOVIC, MARCIA; HOMEM DE MELLO, PATRICIA COTTING; BUCHAIN, PATRICIA CARDOSO; VIZZOTTO, ADRIANA DIAS; HARDER, JANAINA; STELLA, FLORINDO; PIERSOL, CATHERINE VERRIER; GITLIN, LAURA N.; FORLENZA, ORESTES VICENTE. An intervention to reduce neuropsychiatric symptoms and caregiver burden in dementia: Preliminary results from a randomized trial of the tailored activity program-outpatient version. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v. 34, n. 9, SI, p. 1301-1307, . (16/01302-9, 09/52825-8, 14/14211-6)
GLENDA DIAS SANTOS; PAULA VILLELA NUNES; FLORINDO STELLA; PAULA SCHIMIDT BRUM; MONICA SANCHES YASSUDA; LINDA MASSAKO UENO; WAGNER FARID GATTAZ; ORESTES VICENTE FORLENZA. Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia. ARCHIVES OF CLINICAL PSYCHIATRY, v. 42, n. 6, p. 153-156, . (09/52825-8)
DORLI KAMKHAGI; ANA CAROLINA OLIVEIRA COSTA; SANDRA KUSMINSKY; DEBORAH SUPINO; BRENO SATLER DINIZ; WAGNER FARID GATTAZ; ORESTES VICENTE FORLENZA. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients. ARCHIVES OF CLINICAL PSYCHIATRY, v. 42, n. 6, p. 157-160, . (09/52825-8)
STELLA, FLORINDO; RADANOVIC, MARCIA; APRAHAMIAN, IVAN; CANINEU, PAULO RENATO; DE ANDRADE, LARISSA PIRES; FORLENZA, ORESTES VICENTE. Neurobiological Correlates of Apathy in Alzheimer's Disease and Mild Cognitive Impairment: A Critical Review. JOURNAL OF ALZHEIMER'S DISEASE, v. 39, n. 3, p. 633-648, . (09/52825-8)
FORLENZA, O. V.; DE-PAULA, V. J. R.; DINIZ, B. S. O.. Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer's Disease and Related Neurodegenerative Disorders. ACS Chemical Neuroscience, v. 5, n. 6, p. 443-450, . (09/52825-8)
CARDILLO, GIANCARLO DE MATTOS; RODRIGUES DE-PAULA, VANESSA DE JESUS; IKENAGA, ELIZA HIROMI; COSTA, LUCIANA RODRIGUES; CATANOZI, SERGIO; SCHAEFFER, EVELIN LISETE; GATTAZ, WAGNER FARID; KERR, DANIEL SHIKANAI; FORLENZA, ORESTES VICENTE. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice. JOURNAL OF ALZHEIMER'S DISEASE, v. 63, n. 1, p. 93-101, . (14/14211-6, 09/52825-8, 16/01302-9)
DE-PAULA, VANESSA DE J. R.; FORLENZA, ANDREA S.; FORLENZA, ORESTES V.. Relevance of gutmicrobiota in cognition, behaviour and Alzheimer's disease. PHARMACOLOGICAL RESEARCH, v. 136, p. 29-34, . (16/01302-9, 13/20695-3, 09/52825-8)
STELLA, FLORINDO; FORLENZA, ORESTES VICENTE; LAKS, JERSON; DE ANDRADE, LARISSA PIRES; CACAO, JOAO DE CASTILHO; GOVONE, JOSE SILVIO; DE MEDEIROS, KATE; LYKETSOS, CONSTANTINE G.. Caregiver report versus clinician impression: disagreements in rating neuropsychiatric symptoms in Alzheimer's disease patients. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v. 30, n. 12, p. 1230-1237, . (10/18999-6, 09/52825-8)
MIRANDEZ, ROBERTA M.; APRAHAMIAN, IVAN; TALIB, LEDA L.; FORLENZA, ORESTES V.; RADANOVIC, MARCIA. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease. INTERNATIONAL PSYCHOGERIATRICS, v. 29, n. 6, p. 949-958, . (09/52825-8)
MEMORIA, CLAUDIA M.; YASSUDA, MONICA S.; NAKANO, EDUARDO Y.; FORLENZA, ORESTES V.. Contributions of the Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment (CANS-MCI) for the diagnosis of MCI in Brazil. INTERNATIONAL PSYCHOGERIATRICS, v. 26, n. 9, p. 1483-1491, . (09/52825-8)
TALIB, L. L.; HOTOTIAN, S. R.; JOAQUIM, H. P. G.; FORLENZA, O. V.; GATTAZ, W. F.. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 265, n. 8, p. 701-706, . (02/13633-7, 09/52825-8)
TALIB, LEDA L.; VALENTE, KETTE D.; VINCENTIIS, SILVIA; GATTAZ, WAGNER F.. Correlation between platelet and brain PLA(2) activity. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, v. 89, n. 4, p. 265-268, . (09/52825-8)
TEIXEIRA, ANTONIO L.; DINIZ, BRENO S.; CAMPOS, ALLINE C.; MIRANDA, ALINE S.; ROCHA, NATALIA P.; TALIB, LEDA L.; GATTAZ, WAGNER F.; FORLENZA, ORESTES V.. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer's Disease. NEUROMOLECULAR MEDICINE, v. 15, n. 1, p. 115-121, . (09/52825-8)
ORESTES V. FORLENZA; BRENO S. DINIZ; FLORINDO STELLA; ANTONIO L. TEIXEIRA; WAGNER F. GATTAZ. Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia. Revista Brasileira de Psiquiatria, v. 35, n. 2, p. 178-185, . (09/52825-8)
DINIZ, BRENO S.; TEIXEIRA, ANTONIO L.; MACHADO-VIEIRA, RODRIGO; TALIB, LEDA L.; GATTAZ, WAGNER F.; FORIENZA, ORESTES V.. Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, v. 21, n. 5, p. 493-496, . (09/52825-8)
FORLENZA, ORESTES VICENTE; MIRANDA, ALINE SILVA; BARBOSA, IZABELA GUIMARAES; TALIB, LEDA LEME; DINIZ, BRENO SATLER; GATTAZ, WAGNER FARID; TEIXEIRA, ANTONIO LUCIO. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects. JOURNAL OF ALZHEIMER'S DISEASE, v. 46, n. 2, p. 423-429, . (09/52825-8)
SCHAEFFER, EVELIN L.; CATANOZI, SERGIO; WEST, MARK J.; GATTAZ, WAGNER F.. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice. ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, v. 209, p. 51-60, . (09/52825-8)
KAMKHAGI, DORLI; OLIVEIRA COSTA, ANA CAROLINA; KUSMINSKY, SANDRA; SUPINO, DEBORAH; DINIZ, BRENO SATLER; GATTAZ, WAGNER FARID; FORLENZA, ORESTES VICENTE. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer's disease patients. ARCHIVES OF CLINICAL PSYCHIATRY, v. 42, n. 6, p. 157-160, . (09/52825-8)
KERR, DANIEL SHIKANAI; STELLA, FLORINDO; RADANOVIC, MARCIA; APRAHAMIAN, IVAN; FERREIRA BERTOLLUCCI, PAULO HENRIQUE; FORLENZA, ORESTES VICENTE. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder. BIPOLAR DISORDERS, v. 18, n. 1, p. 71-77, . (13/01352-8, 09/52825-8)
DUITS, FLORA H.; MARTINEZ-LAGE, PABLO; PAQUET, CLAIRE; ENGELBORGHS, SEBASTIAAN; LLEO, ALBERTO; HAUSNER, LUCREZIA; MOLINUEVO, JOSE L.; STOMRUD, ERIK; FAROTTI, LUCIA; RAMAKERS, INEZ H. G. B.; et al. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study. ALZHEIMERS & DEMENTIA, v. 12, n. 2, p. 154-163, . (09/52825-8)
RADANOVIC, MARCIA; OSHIRO, CARLOS A.; FREITAS, THIAGO Q.; TALIB, LEDA L.; FORLENZA, ORESTES V.. Correlation between CSF biomarkers of Alzheimer's disease and global cognition in a psychogeriatric clinic cohort. Revista Brasileira de Psiquiatria, v. 41, n. 6, p. 479-484, . (09/52825-8, 16/01302-9, 14/14211-6)
DINIZ, BRENO S.; TEIXEIRA, ANTONIO L.; TALIB, LEDA L.; GATTAZ, WAGNER F.; FORLENZA, ORESTES V.. Circulating Nerve Growth Factor in elderly subjects: state marker of depression?. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, v. 20, n. 3, p. 2-pg., . (09/52825-8)
DE OLIVEIRA, ALEXANDRA MARTINI; RADANOVIC, MARCIA; HOMEM DE MELLO, PATRICIA COTTING; BUCHAIN, PATRICIA CARDOSO; BARBOSA VIZZOTTO, ADRIANA DIAS; CELESTINO, DIEGO L.; STELLA, FLORINDO; PIERSOL, CATHERINE V.; FORLENZA, ORESTES V.. Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review. BIOMED RESEARCH INTERNATIONAL, v. 2015, p. 9-pg., . (09/52825-8)
VACAS, SARA M.; STELLA, FLORINDO; LOUREIRO, JULIA C.; DO COUTO, FREDERICO SIMOES; OLIVEIRA-MAIA, ALBINO J.; FORLENZA, ORESTES V.. Noninvasive brain stimulation for behavioural and psychological symptoms of dementia: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v. 34, n. 9, p. 9-pg., . (16/01302-9, 14/14211-6, 09/52825-8)
ROCHA, NICOLE KEMBERLY R.; THEMOTEO, RAFAEL; BRENTANI, HELENA; FORLENZA, ORESTES V.; DE PAULA, VANESSA DE JESUS RODRIGUES. Neuronal-Glial Interaction in a Triple-Transgenic Mouse Model of Alzheimer's Disease: Gene Ontology and Lithium Pathways. FRONTIERS IN NEUROSCIENCE, v. 14, . (17/14418-8, 11/19892-3, 16/01302-9, 09/52825-8, 18/08621-8, 14/50873-3)
OLIVEIRA, ALEXANDRA MARTINI; RADANOVIC, MARCIA; HOMEM DE MELLO, PATRICIA COTTING; BUCHAIN, PATRICIA CARDOSO; BARBOSA VIZZOTTO, ADRIANA DIAS; HARDER, JANAINA; STELLA, FLORINDO; GITLIN, LAURA N.; PIERSOL, CATHERINE VERRIER; VALIENGO, LEANDRO L. C.; et al. Adjunctive Therapy to Manage Neuropsychiatric Symptoms in Moderate and Severe Dementia: Randomized Clinical Trial Using an Outpatient Version of Tailored Activity Program. JOURNAL OF ALZHEIMER'S DISEASE, v. 83, n. 1, p. 475-486, . (14/14211-6, 16/01302-9, 09/52825-8)
MÁRCIA RADANOVIC; CARLOS A. OSHIRO; THIAGO Q. FREITAS; LEDA L. TALIB; ORESTES V. FORLENZA. Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort. Revista Brasileira de Psiquiatria, n. ahead, p. -, . (09/52825-8, 16/01302-9, 14/14211-6)
FORLENZA, ORESTES V.; LOUREIRO, JULIA CUNHA; PAIS, MARCOS VASCONCELOS; STELLA, FLORINDO. Recent advances in the management of neuropsychiatric symptoms in dementia. CURRENT OPINION IN PSYCHIATRY, v. 30, n. 2, p. 151-158, . (09/52825-8)
STELLA, FLORINDO; RADANOVIC, MARCIA; CANINEU, PAULO RENATO; DE PAULA, VANESSA J. R.; FORLENZA, ORESTES V.. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. THERAPEUTIC ADVANCES IN DRUG SAFETY, v. 6, n. 4, p. 151-165, . (09/52825-8)
RADANOVIC, MARCIA; FACCO, GIULIANA; FORLENZA, ORESTES V.. Sensitivity and specificity of a briefer version of the Cambridge Cognitive Examination (CAMCog-Short) in the detection of cognitive decline in the elderly: An exploratory study. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v. 33, n. 5, p. 769-778, . (09/52825-8, 13/20695-3)
IBARRA, ROMEL; RADANOVIC, MARCIA; PAIS, V, MARCOS; TALIB, LEDA L.; FORLENZA, V, ORESTES. AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, v. 34, n. 6, SI, p. 659-667, . (09/52825-8, 16/01302-9, 14/14211-6)
MÁRCIA RADANOVIC; CARLOS A. OSHIRO; THIAGO Q. FREITAS; LEDA L. TALIB; ORESTES V. FORLENZA. Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort. Revista Brasileira de Psiquiatria, v. 41, n. 6, p. 479-484, . (14/14211-6, 16/01302-9, 09/52825-8)
IBARRA, ROMEL; RADANOVIC, MARCIA; PAIS, V, MARCOS; TALIB, LEDA L.; FORLENZA, V, ORESTES. AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, . (09/52825-8, 16/01302-9, 14/14211-6)
VACAS, SARA M.; STELLA, FLORINDO; LOUREIRO, JULIA C.; DO COUTO, FREDERICO SIMOES; OLIVEIRA-MAIA, ALBINO J.; FORLENZA, ORESTES V.. Noninvasive brain stimulation for behavioural and psychological symptoms of dementia: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v. 34, n. 9, SI, p. 1336-1344, . (16/01302-9, 09/52825-8, 14/14211-6)
ORESTES V. FORLENZA; BRENO S. DINIZ; ANTONIO L. TEIXEIRA; FLORINDO STELLA; WAGNER GATTAZ. Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease. Revista Brasileira de Psiquiatria, v. 35, n. 3, p. 284-294, . (09/52825-8)
BRAM, JESSYKA MARIA DE FRANCA; TALIB, LEDA LEME; JOAQUIM, HELENA PASSARELLI GIROUD; SARNO, TAMIRES ALVES; GATTAZ, WAGNER FARID; FORLENZA, ORESTES VICENTE. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 269, n. 8, p. 963-972, . (13/20695-3, 09/52825-8)
DE-PAULA, VANESSA J.; DOS SANTOS, CARLA CRISTINE C.; LUQUE, MARIA CAROLINA A.; ALI, TACCYANA M.; KALIL, JORGE E.; FORLENZA, ORESTES V.; CUNHA-NETO, EDECIO. Acute and chronic lithium treatment increases Wnt/beta-catenin transcripts in cortical and hippocampal tissue at therapeutic concentrations in mice. METABOLIC BRAIN DISEASE, v. 36, n. 1, . (14/50890-5, 11/19892-3, 09/52825-8, 16/01302-9)
STELLA, FLORINDO; LOUREIRO, JULIA C.; PAIS, MARCOS V.; CANINEU, PAULO R.; FORLENZA, ORESTES V.. Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function. CURRENT DRUG METABOLISM, v. 19, n. 8, p. 641-652, . (09/52825-8)
LOUREIRO, JULIA C.; PAIS, MARCOS V.; STELLA, FLORINDO; RADANOVIC, MARCIA; TEIXEIRA, ANTONIO LUCIO; FORLENZA, ORESTES V.; DE SOUZA, LEONARDO CRUZ. Passive antiamyloid immunotherapy for Alzheimer's disease. CURRENT OPINION IN PSYCHIATRY, v. 33, n. 3, p. 284-291, . (09/52825-8)
SANTOS, GLENDA DIAS; NUNES, PAULA VILLELA; STELLA, FLORINDO; BRUM, PAULA SCHIMIDT; YASSUDA, MONICA SANCHES; UENO, LINDA MASSAKO; GATTAZ, WAGNER FARID; FORLENZA, ORESTES VICENTE. Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer's disease and cognitive impairment without dementia. ARCHIVES OF CLINICAL PSYCHIATRY, v. 42, n. 6, p. 153-156, . (09/52825-8)
FORLENZA, ORESTES V.; APRAHAMIAN, IVAN; RADANOVIC, MARCIA; TALIB, LEDA L.; CAMARGO, MARINA Z. A.; STELLA, FLORINDO; MACHADO-VIEIRA, RODRIGO; GATTAZ, WAGNER F.. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. BIPOLAR DISORDERS, v. 18, n. 1, p. 63-70, . (09/52825-8)
SARNO, TAMIRES ALVES; TALIB, LEDA LEME; GIROUD JOAQUIM, HELENA PASSARELLI; DE FRANCA BRAM, JESSYKA MARIA; GATTAZ, WAGNER FARID; FORLENZA, ORESTES VICENTE. Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. JOURNAL OF ALZHEIMER'S DISEASE, v. 55, n. 4, p. 1445-1451, . (13/20695-3, 09/52825-8)
FORLENZA, ORESTES V.; APRAHAMIAN, IVAN; DE PAULA, VANESSA J.; HAJEK, TOMAS. Lithium, a Therapy for AD: Current Evidence from Clinical Trials of Neurodegenerative Disorders. Current Alzheimer Research, v. 13, n. 8, p. 879-886, . (09/52825-8)
DE-PAULA, VANESSA DE JESUS; KERR, DANIEL SHIKANAI; FABIANO DE CARVALHO, MARILIA PALMA; SCHAEFFER, EVELIN LISETE; TALIB, LEDA LEME; GATTAZ, WAGNER FARID; FORLENZA, ORESTES VICENTE. Long-Term Lithium Treatment Increases cPLA(2) and iPLA(2) Activity in Cultured Cortical and Hippocampal Neurons. Molecules, v. 20, n. 11, p. 19878-19885, . (11/19892-3, 09/52825-8)
MURY, FABIO B.; DA SILVA, WEBER C.; BARBOSA, NADIA R.; MENDES, CAMILA T.; BONINI, JULIANA S.; SOUZA SARKIS, JORGE EDUARDO; CAMMAROTA, MARTIN; IZQUIERDO, IVAN; GATTAZ, WAGNER F.; DIAS-NETO, EMMANUEL. Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 266, n. 7, p. 607-618, . (04/01478-2, 04/02165-8, 09/52825-8)
DINIZ, BRENO S.; TEIXEIRA, ANTONIO L.; MACHADO-VIEIRA, RODRIGO; TALIB, LEDA L.; RADANOVIC, MARCIA; GATTAZ, WAGNER F.; FORLENZA, ORESTES V.. Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, v. 69, n. 6, p. 845-851, . (09/52825-8)
SCHAEFFER, EVELIN L.; CERULLI, FABIANA G.; SOUZA, HELIO O. X.; CATANOZI, SERGIO; GATTAZ, WAGNER F.. Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus. JOURNAL OF NEURAL TRANSMISSION, v. 121, n. 7, p. 695-706, . (11/24022-8, 09/52825-8, 09/53008-3, 11/23039-4)
FORLENZA, ORESTES V.; NOVAES COUTINHO, ARTUR MARTINS; APRAHAMIAN, IVAN; PRANDO, SILVANA; MENDES, LUCIANA LUCAS; DINIZ, BRENO S.; GATTAZ, WAGNER F.; BUCHPIGUEL, CARLOS A.. Long-Term Lithium Treatment Reduces Glucose Metabolism in the Cerebellum and Hippocampus of Nondemented Older Adults: An [F-18]FDG-PET Study. ACS Chemical Neuroscience, v. 5, n. 6, p. 484-489, . (09/52825-8)
MÁRCIA RADANOVIC; FLORINDO STELLA; LIS GOMES SILVA; LEDA L. TALIB; ORESTES V. FORLENZA. AUMENTO DOS NÍVEIS DE CSF DE TAU TOTAL EM PACIENTES COM PATOLOGIA SUBCUTÂNEA CEREBROVASCULAR E COMPROMETIMENTO COGNITIVO. Dement. Neuropsychol., v. 11, n. 4, p. 419-425, . (09/52825-8)
SCHAEFFER, EVELIN L.; GATTAZ, WAGNER F.. Chronic inhibition of brain phospholipase A(2) in adult rats impairs the survival of newborn mature neurons in the hippocampus. JOURNAL OF NEURAL TRANSMISSION, v. 122, n. 5, p. 619-628, . (09/52825-8, 09/53008-3, 10/05442-3)
FORLENZA, ORESTES V.; RADANOVIC, MARCIA; TALIB, LEDA L.; GATTAZ, WAGNER F.. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. BRITISH JOURNAL OF PSYCHIATRY, v. 215, n. 5, p. 668-674, . (09/52825-8)
DE OLIVEIRA, ALEXANDRA MARTINI; RADANOVIC, MARCIA; HOMEM DE MELLO, PATRICIA COTTING; BUCHAIN, PATRICIA CARDOSO; VIZZOTTO, ADRIANA DIAS; HARDER, JANAINA; STELLA, FLORINDO; PIERSOL, CATHERINE VERRIER; GITLIN, LAURA N.; FORLENZA, ORESTES VICENTE. An intervention to reduce neuropsychiatric symptoms and caregiver burden in dementia: Preliminary results from a randomized trial of the tailored activity program-outpatient version. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v. 34, n. 9, p. 7-pg., . (09/52825-8, 16/01302-9, 14/14211-6)
ZAINAGHI, ISIS A.; TALIB, LEDA L.; DINIZ, BRENO S.; GATTAZ, WAGNER F.; FORLENZA, ORESTES V.. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION, v. 119, n. 7, p. 5-pg., . (09/52825-8)

Por favor, reporte erros na lista de publicações científicas utilizando este formulário.
X

Reporte um problema na página


Detalhes do problema: